Search Results for: Cancer

October 14, 2024October 14, 2024

Novel SARS-CoV-2 inhibition properties of the anti-cancer Kang Guan Recipe herbal formula.

Publication date: Nov 01, 2024 The ongoing COVID-19 pandemic is a persistent challenge, with continued breakthrough infections despite vaccination efforts. This has spurred interest in alternative preventive measures, including dietary ... Read more

October 13, 2024October 13, 2024

Impact of the COVID-19 pandemic on lung cancer diagnoses and mortality: A nationwide study in France.

Coronavirus Literature

Publication date: Oct 10, 2024 During the first wave of the COVID-19 pandemic, a reduction in the number of newly diagnosed cases of lung cancer has been reported worldwide, often ... Read more

October 12, 2024October 12, 2024

Quality of life under treatment with the immune checkpoint inhibitors ipilimumab and nivolumab in melanoma patients. Real-world data from a prospective observational study at the Skin Cancer Center Kiel.

Melanoma Literature

Publication date: Oct 10, 2024 Combined immunotherapy (ipilimumab + nivolumab) has improved survival in stage IV melanoma patients, making Health-related Quality of Life (HrQoL) crucial due to potential immune-related adverse events (irAEs). ... Read more

October 12, 2024October 12, 2024

Quality of life under treatment with the immune checkpoint inhibitors ipilimumab and nivolumab in melanoma patients. Real-world data from a prospective observational study at the Skin Cancer Center Kiel.

Melanoma Literature

October 12, 2024October 12, 2024

Evaluating the concentration dependent dual effects of β-Glucan on cancerous skin cells and mitochondria isolated from melanoma-induced animal model.

Melanoma Literature

Publication date: Oct 11, 2024 Melanoma is still one of the deadliest cancers whose prevalence has increased in recent decades. Today, many polysaccharides and their bioactive compounds have been of ... Read more

October 12, 2024October 12, 2024

Evaluating the concentration dependent dual effects of β-Glucan on cancerous skin cells and mitochondria isolated from melanoma-induced animal model.

Melanoma Literature

October 12, 2024October 12, 2024

Disparities in the Care Disruption During COVID-19 and in its Impacts on the Mental and Physical Well-Being of Cancer Survivors.

Coronavirus Literature

Publication date: Nov 01, 2024 Our study explores cancer care disruption among different demographic subgroups. It also investigates these disruptions’ impacts on cancer survivors’ mental and physical well-being. Pooled cross-sectional ... Read more

October 11, 2024October 11, 2024

Primary nipple melanoma in a patient with breast cancer: A diagnosis to consider.

Melanoma Literature

Publication date: Dec 01, 2024 Melanoma in situ of the nipple is an uncommon diagnosis, with only a few reports in the literature. Due to the variety of pathologies that ... Read more

October 10, 2024October 10, 2024

A genetically informed study reveals modifiable pathways in skin cancer.

Melanoma Literature

Publication date: Oct 08, 2024 Identifying modifiable risk factors is essential for the prevention of skin cancer; however, establishing causality can be challenging in conventional epidemiological studies. This study aimed ... Read more

October 10, 2024October 10, 2024

Estimating Long-Term Survivorship Rates Among Patients With Resected Stage III/IV Melanoma: Analyses From CheckMate 238 and European Organization for Research and Treatment of Cancer 18071 Trials.

Melanoma Literature

Publication date: Oct 08, 2024 Standard-of-care treatments for patients with resected stage III/IV melanoma include the immuno-oncology (IO) agents nivolumab (NIVO) and ipilimumab (IPI). This study used mixture cure models ... Read more